RegeneRx Biopharmaceuticals, Inc. (RGRX)
RGRX Stock Price Chart
Explore RegeneRx Biopharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze RGRX price movements and trends.
RGRX Company Profile
Discover essential business fundamentals and corporate details for RegeneRx Biopharmaceuticals, Inc. (RGRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 Oct 2003
Employees
2.00
Website
https://www.regenerx.comCEO
J. J. Finkelstein
Description
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.
RGRX Financial Timeline
Browse a chronological timeline of RegeneRx Biopharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 18 Oct 2023
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 14 Aug 2023
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2023
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 31 Dec 2022
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 30 Sept 2022
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 30 Jun 2022
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 31 Mar 2022
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 15 Nov 2021
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 6 Aug 2021
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 31 Mar 2021
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 31 Dec 2020
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
Earnings released on 13 Nov 2020
EPS came in at -$0.00 , while revenue for the quarter reached $19.19K .
RGRX Stock Performance
Access detailed RGRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.